2009
DOI: 10.1001/archpedi.163.2.164
|View full text |Cite
|
Sign up to set email alerts
|

Incidence of Noninfectious Conditions in Perinatally HIV-Infected Children and Adolescents in The HAART Era

Abstract: Objective: To estimate highly active antiretroviral therapy (HAART)-era incident rates for the first episode of noninfectious conditions in human immunodeficiency virus (HIV)-infected youth in order to identify HAART-era changes in the natural history of perinatal HIV infection.Design: Multicenter prospective cohort study. Conclusions: Between 2001 and 2006, the incidence for 3 conditions decreased and increased for 2 others, demonstrating the change in medical issues and conditions in perinatally infected you… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
35
0
3

Year Published

2010
2010
2018
2018

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(39 citation statements)
references
References 29 publications
1
35
0
3
Order By: Relevance
“…Patients infected with HIV are 35 to 800 times more likely to develop AP than the general population. In a recent multicentric study of 2575 HIV-infected children, among the incidence of non infectious conditions, pancreatitis constitutes approximately 0.30% [3]. Antiretroviral agents linked to AP include nucleoside reverse transcriptase inhibitors (NRTI) and protease inhibitors (PI).…”
Section: Discussionmentioning
confidence: 99%
“…Patients infected with HIV are 35 to 800 times more likely to develop AP than the general population. In a recent multicentric study of 2575 HIV-infected children, among the incidence of non infectious conditions, pancreatitis constitutes approximately 0.30% [3]. Antiretroviral agents linked to AP include nucleoside reverse transcriptase inhibitors (NRTI) and protease inhibitors (PI).…”
Section: Discussionmentioning
confidence: 99%
“…Важность назначения высокоактивной антиретрови-русной терапии (ВААРТ) определяется неблагоприятным течением ВИЧ-инфекции у детей, быстрым развитием иммуносупрессии, приводящей к присоединению тяже-лых оппортунистических инфекций, развитию злокаче-ственных опухолей и в конечном итоге к летальному исхо-ду [1,2]. ВААРТ позволяет подавить репликацию вируса иммунодефицита человека (ВИЧ), о чем свидетельствует снижение уровня вирусемии (вирусной нагрузки кро-ви, ВНК) < 50 копий/мл.…”
Section: обоснованиеunclassified
“…As survival has been prolonged in perinatally HIV-infected children and adolescents in the HAART era and many of them are now reaching adulthood, an increase in the incidence rates over time in pregnancy-related conditions and gynaecological dysplasia is being observed in parallel with a decrease of the incidence of the other non infectious conditions. (Nachman et al, 2009) (CDC 1993) www.intechopen.com…”
Section: Clinical Manifestations Of Hiv-infection In the Era Of Haartmentioning
confidence: 99%